Background: Cognition may be affected at least as seriously as physical function during multiple sclerosis (MS) relapse, however MS relapse related cognitive disorders are still underdiagnosed and poorly characterized. The limited number of paper-pencil tests were used for assessment, and nevertheless, some significant changes were found. Unlike the paper-pencil tests, computerized batteries and tests are more sensitive and highly standardized, produce instant scoring and can minimize the learning and practice effects on follow-up. We investigated the cognition during MS relapse with the Cambridge Neuropsychological Test Automated Battery (CANTAB), which has shown sensitivity to cognitive dysfunction across different clinical groups, includ...
Cognitive dysfunction is considered one of the clinical markers of multiple sclerosis (MS). However,...
Cognitive dysfunction is considered one of the clinical markers of multiple sclerosis (MS). However,...
Multiple sclerosis (MS) is a progressive chronic disease of the Central Nervous System (CNS). Cognit...
Abstract Background It is essential to investigate cognitive deficits in multiple sclerosis (MS) to ...
The purpose of the study was to identify changes in cognitive abilities that affect patients with re...
Cognitive dysfunction is present in up to 70% of patients with multiple sclerosis (MS) and has been ...
Objective During acute relapses of multiple sclerosis (MS), physical symptoms attract utmost care. H...
The purpose of this study is to evaluate the cognitive functions in cases with relapsing remitting M...
There is some evidence that cognition may be impaired during multiple sclerosis (MS) relapse. The ai...
Abstract Background There is need for a cognitive test battery that can be easily used in clinical p...
Detecting cognitive dysfunction may be clinically important during the early stages of multiple scle...
Cognitive dysfunction is considered one of the clinical markers of multiple sclerosis (MS). However,...
WOS: 000356420100013PubMed ID: 28360700Introduction: The aims of this study were to determine the se...
The purpose of this study is to evaluate the cognitive functions in cases with relapsing remitting M...
Cognitive dysfunction is considered one of the clinical markers of multiple sclerosis (MS). However,...
Cognitive dysfunction is considered one of the clinical markers of multiple sclerosis (MS). However,...
Cognitive dysfunction is considered one of the clinical markers of multiple sclerosis (MS). However,...
Multiple sclerosis (MS) is a progressive chronic disease of the Central Nervous System (CNS). Cognit...
Abstract Background It is essential to investigate cognitive deficits in multiple sclerosis (MS) to ...
The purpose of the study was to identify changes in cognitive abilities that affect patients with re...
Cognitive dysfunction is present in up to 70% of patients with multiple sclerosis (MS) and has been ...
Objective During acute relapses of multiple sclerosis (MS), physical symptoms attract utmost care. H...
The purpose of this study is to evaluate the cognitive functions in cases with relapsing remitting M...
There is some evidence that cognition may be impaired during multiple sclerosis (MS) relapse. The ai...
Abstract Background There is need for a cognitive test battery that can be easily used in clinical p...
Detecting cognitive dysfunction may be clinically important during the early stages of multiple scle...
Cognitive dysfunction is considered one of the clinical markers of multiple sclerosis (MS). However,...
WOS: 000356420100013PubMed ID: 28360700Introduction: The aims of this study were to determine the se...
The purpose of this study is to evaluate the cognitive functions in cases with relapsing remitting M...
Cognitive dysfunction is considered one of the clinical markers of multiple sclerosis (MS). However,...
Cognitive dysfunction is considered one of the clinical markers of multiple sclerosis (MS). However,...
Cognitive dysfunction is considered one of the clinical markers of multiple sclerosis (MS). However,...
Multiple sclerosis (MS) is a progressive chronic disease of the Central Nervous System (CNS). Cognit...